Search hospitals > Massachusetts > Boston
Dana Farber Cancer Institute
Claim this profileBoston, Massachusetts 02215
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lymphoma
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Solid Tumors
3428 reported clinical trials
268 medical researchers
Summary
Dana Farber Cancer Institute is a medical facility located in Boston, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Lymphoma, Adult T-Cell Leukemia/Lymphoma, Solid Tumors and other specialties. Dana Farber Cancer Institute is involved with conducting 3,428 clinical trials across 1,465 conditions. There are 268 research doctors associated with this hospital, such as Susan Chi, MD, Geoffrey I. Shapiro, Haeseong Park, MD, and Ryan Sullivan, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Susan Chi, MDDana-Farber Cancer Institute5 years of reported clinical research
Expert in Brain Tumor
Expert in Gliomas
29 reported clinical trials
62 drugs studied
Geoffrey I. ShapiroDana-Farber Cancer Institute8 years of reported clinical research
Expert in Cancer
Expert in Solid Tumors
27 reported clinical trials
57 drugs studied
Haeseong Park, MDWashington University School of Medicine6 years of reported clinical research
Expert in Esophageal Cancer
Studies Cancer
27 reported clinical trials
55 drugs studied
Ryan Sullivan, MDMassachusetts General Hospital3 years of reported clinical research
Expert in Melanoma
Expert in Solid Tumors
22 reported clinical trials
35 drugs studied
Clinical Trials running at Dana Farber Cancer Institute
Breast Cancer
Ovarian Cancer
Multiple Myeloma
Lymphoma
Lung Cancer
Prostate Cancer
Cancer
Non-Small Cell Lung Cancer
Brain Tumor
Melanoma
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Avelumab + Palbociclib/Hydroxychloroquine
for Breast Cancer
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are found to harbor disseminated tumor cells (DTCs) in the bone marrow after definitive surgery and standard adjuvant therapy.
Recruiting3 awards Phase 212 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Dana Farber Cancer Institute?
Dana Farber Cancer Institute is a medical facility located in Boston, Massachusetts. This center is recognized for care of Breast Cancer, Cancer, Lymphoma, Adult T-Cell Leukemia/Lymphoma, Solid Tumors and other specialties. Dana Farber Cancer Institute is involved with conducting 3,428 clinical trials across 1,465 conditions. There are 268 research doctors associated with this hospital, such as Susan Chi, MD, Geoffrey I. Shapiro, Haeseong Park, MD, and Ryan Sullivan, MD.
Where is Dana Farber Cancer Institute located?
The Dana Farber Cancer Institute is situated at 450 Brookline Ave, Boston, MA 02215, within the Longwood Medical Area. For access from the north, utilize I-93, the Tobin Bridge (Route 1), and Route 28, directing towards Storrow Drive, then proceed for 1.5 miles. Follow the exit for Kenmore Square/Fenway, Route 1S, stay in the far left lane, and continue onto Boylston Street (outbound), then bear slight left onto Brookline Avenue, and turn left onto Jimmy Fund Way to find the parking garage entrance on the right.
Who should I call to ask about financial aid or insurance network?
**Dana Farber Cancer Institute Contact Information:**
- **Patient Billing Solutions Team:** For general financial inquiries and assistance with the Patient Financial Assistance program, call 617-632-3795.
- **Shapiro Center for Patients and Families:** For insurance and financial information questions, contact 617-632-3750.
- **International Office:** Specialized support for international patients is available.
- **Language Assistance:** Spanish-speaking patients can call 617-632-3673. For all other languages, please call 617-632-6366.
**Address:** 450 Brookline Ave., Boston, MA 02215-5450.
What insurance does Dana Farber Cancer Institute accept?
The Dana Farber Cancer Institute accepts a wide range of insurance plans, such as Aetna, Allways Health Partners, AmeriHealth, Anthem, Cigna, Humana, Oscar, and UnitedHealthcare. It is now an in-network provider for the Boston Medical Center HealthNet Plan (BMCHP), catering to Massachusetts residents, including MassHealth members from marginalized communities, individuals with disabilities, and seniors. The hospital offers specialized services for international patients and financial counseling for uninsured or low-income individuals to explore coverage options.
What awards or recognition has Dana Farber Cancer Institute received?
The Dana-Farber Cancer Institute in Boston, Massachusetts, is renowned for its exceptional research and care in the field of cancer. It has been recognized as one of the most noteworthy companies and non-profits led by women in Massachusetts. Furthermore, 24 of its researchers have been acknowledged as Highly Cited Researchers, underscoring their significant global impact on cancer research.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.